Olivera Finn, University of Pittsburgh, talks about the possibility to develop universal vaccines for preventing cancer, and maybe also infectious and chronic diseases.
Mark Davis, Stanford University, explains how immune monitoring may soon help us to be more consciuos of our health and to predict our response to infectious disease or vaccine, for example flu vaccine.
Luciano Adorini, president on the XVth International Congress of Immunology, highlights the scientific impact of the event.
Sergio Romagnani (University of Florence, Italy), honorary president of the congress, underlines the importance of this event for Italian immunology and how new technologies widens perspectives of human immunology.
Jules Hoffmann, Nobel Prize laureate, confirms the importance of research that is not immediately directed towards its practical application.
Abul Abbas (University of California, San Francisco) explains how immune tolerance can be manipulated in order to improve therapies against several diseases, including cancer.
Diane Mathis (Harvard Medical School) explains which factors play a role in the development of autoimmune diseases: genes, lifestyles and not so many viruses.
Peter C. Doherty and Rolf M. Zinkernagel discuss about new perspectives in immunology.
